Somalogic Inc (SLGC) Inventory Turnover Ratio, from third quarter 2023 to third quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Somalogic Inc   (NASDAQ: SLGC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Somalogic Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Somalogic Inc inventory turnover ratio, the Somalogic Inc 's ability to sell and replace its inventory in the third quarter 2023, sequentially increased to 3.01 in the third quarter 2023, a new company high. Average inventory processing period, for the Somalogic Inc in Sep 30 2023 quarter, has decreased to 121 days, compare to 127 days, in the Jun 30 2023 quarter.

Within Healthcare sector 136 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2023, to 714, from total ranking in the second quarter 2023 at 1032.

SLGC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Somalogic Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SLGC Inventory Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Inventory Growth -24.95 % -27.18 % 5.72 % 23.94 % 73.76 %
Y / Y Cost of Sales Growth -11.27 % 47.27 % 2.65 % 39.68 % 28.92 %
Inventory Turnover Ratio (TTM) 3.01 2.87 2.45 2.46 2.35
SLGC's Total Ranking # 714 # 1032 # 1169 # 1349 # 1436
Average inventory processing period 121 127 149 148 156
Seq. Inventory Growth -8.19 % 0.48 % 8.3 % -24.88 % -10.93 %
Seq. Cost of Sales Growth 3.28 % -17.16 % -4.28 % 8.35 % 71.42 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 14
Healthcare Sector # 137
Overall Market # 714

Inventory Turnover Ratio Statistics
High Average Low
3.01 2.6 2.35
(Sep 30 2023)   (Sep 30 2022)



SLGC Company Profile >> Back to SLGC Efficiency Comparisons >> Compare SLGC Inventory Turnover Ratio to its Competitors

Financial Statements
Somalogic Inc 's Inventories $ 14 Millions Visit SLGC's Balance sheet
Somalogic Inc 's Cost of Revenues TTM $ 44 Millions Visit SLGC's Income Statement
What are SLGC's Sales? Visit SLGC's Sales by Segment

Other Inventory Turnover Ratios
Somalogic Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SLGC's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SLGC's Competitors
Inventory Turnover Ratio for SLGC's Suppliers
Inventory Turnover Ratio for SLGC's Customers

You may also want to know
SLGC's Sales Growth Rates SLGC's Pe Price to earnings ratio SLGC's Receivables Turnover Ratio SLGC's Stock Quote
SLGC's Net Income Growth Rates SLGC's Ps Price to Sales ratio SLGC's Sales per Employee SLGC's Asset Turnover Ratio
SLGC's Net Margin SLGC's Pb Price to Book ratio SLGC's Financial Strength Ratios SLGC's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2023 Inventories at quarter ending Sep 30 2023
Bionexus Gene Lab Corp   8.57 $ 8.892  Millions$ 1  Millions
Charles River Laboratories International inc   8.51 $ 2,334.261  Millions$ 274  Millions
Kaya Holdings Inc   8.29 $ 0.101  Millions$ 0  Millions
Bioaffinity Technologies Inc   8.28 $ 0.076  Millions$ 0  Millions
Castle Biosciences Inc   8.25 $ 42.079  Millions$ 5  Millions
Scilex Holding Company  8.20 $ 21.957  Millions$ 3  Millions
Ginkgo Bioworks Holdings Inc   8.14 $ 14.928  Millions$ 2  Millions
National Vision Holdings Inc   8.00 $ 976.100  Millions$ 122  Millions
Moderna Inc   7.88 $ 5,682.000  Millions$ 721  Millions
Kewaunee Scientific Corporation  7.68 $ 167.116  Millions$ 22  Millions
Collegium Pharmaceutical Inc   7.57 $ 264.196  Millions$ 35  Millions
Star Equity Holdings Inc   7.56 $ 55.456  Millions$ 7  Millions
Camp4 Therapeutics Corporation  7.39 $ 185.873  Millions$ 25  Millions
Prophase Labs Inc   7.39 $ 31.323  Millions$ 4  Millions
Prosomnus Inc   7.34 $ 8.000  Millions$ 1  Millions
Hims and Hers Health Inc   6.92 $ 148.211  Millions$ 21  Millions
Nutriband Inc   6.89 $ 1.278  Millions$ 0  Millions
Cardiff Lexington Corporation  6.84 $ 3.694  Millions$ 1  Millions
Alimera Sciences Inc  6.63 $ 9.336  Millions$ 1  Millions
Fonar Corporation  6.29 $ 16.810  Millions$ 3  Millions
Societal Cdmo Inc   6.29 $ 73.913  Millions$ 12  Millions
Inogen Inc   6.26 $ 199.843  Millions$ 32  Millions
Veracyte Inc   6.12 $ 84.202  Millions$ 14  Millions
Dmk Pharmaceuticals Corporation  6.04 $ 4.875  Millions$ 1  Millions
Opko Health Inc   6.02 $ 439.790  Millions$ 73  Millions
Patterson Companies Inc   5.89 $ 5,159.279  Millions$ 876  Millions
Carlisle Companies Incorporated  5.76 $ 3,633.900  Millions$ 631  Millions
Incyte Corporation  5.55 $ 244.402  Millions$ 44  Millions
Cytosorbents Corporation  5.50 $ 14.030  Millions$ 3  Millions
Acadia Pharmaceuticals Inc   5.39 $ 26.161  Millions$ 5  Millions

Date modified: 2026-08-29T17:44:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.